Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: INTRAVITREAL INJECTIONS - , 1970. Treffer: 14
2017
Glatz, W; Steinwender, G; Tarmann, L; Malle, EM; Schörkhuber, M; Wackernagel, W; Petrovski, G; Wedrich, A; Ivastinovic, D
Vitreous hyper-reflective dots in pseudophakic cystoid macular edema assessed with optical coherence tomography.
PLoS One. 2017; 12(12):e0189194-e0189194
Doi: 10.1371/journal.pone.0189194
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Palkovits, S; Seidel, G; Pertl, L; Malle, EM; Hausberger, S; Makk, J; Singer, C; Osterholt, J; Herzog, SA; Haas, A; Weger, M
MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Retina. 2017; 37(12):2262-2268
Doi: 10.1097/IAE.0000000000001480
Web of Science
PubMed
FullText
FullText_MUG
2016
Smretschnig, E; Hagen, S; Glittenberg, C; Ristl, R; Krebs, I; Binder, S; Ansari-Shahrezaei, S
Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.
Eye (Lond). 2016; 30(6):805-811
Doi: 10.1038/eye.2016.41
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Kreutzer, TC; Wolf, A; Dirisamer, M; Strauss, RW; Foerster, P; Feltgen, N; Pielen, A; Hattenbach, LO; Kampik, A; Priglinger, SG
Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial.
Ophthalmologica. 2015; 233(1):8-17
Doi: 10.1159/000369566
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Tarmann, L; Langmann, G; Mayer, C; Weger, M; Haas, A; Wackernagel, W
Ozurdex(®) reduces the retinal thickness in radiation maculopathy refractory to bevacizumab.
Acta Ophthalmol. 2014; 92(8):e694-e696
Doi: 10.1111/aos.12424
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Julian, K; Langner-Wegscheider, BJ; Haas, A; De Smet, MD
Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis.
Retina. 2013; 33(9):1943-1948
Doi: 10.1097/IAE.0b013e318285cdbe
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Krebs, I; Glittenberg, C; Ansari-Shahrezaei, S; Hagen, S; Steiner, I; Binder, S
Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration.
Br J Ophthalmol. 2013; 97(11):1443-1446
Doi: 10.1136/bjophthalmol-2013-303513
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Krebs, I; Schmetterer, L; Boltz, A; Told, R; Vécsei-Marlovits, V; Egger, S; Schönherr, U; Haas, A; Ansari-Shahrezaei, S; Binder, S; MANTA Research Group
A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration.
Br J Ophthalmol. 2013; 97(3):266-271
Doi: 10.1136/bjophthalmol-2012-302391
Web of Science
PubMed
FullText
FullText_MUG
Krebs, I; Vécsei Marlovits, V; Bodenstorfer, J; Glittenberg, C; Ansari Shahrezaei, S; Ristl, R; Binder, S
Comparison of Ranibizumab monotherapy versus combination of Ranibizumab with photodynamic therapy with neovascular age-related macular degeneration.
Acta Ophthalmol. 2013; 91(3):e178-e183
Doi: 10.1111/aos.12018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Seidel, G; Werner, C; Weger, M; Steinbrugger, I; Haas, A
Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.
Acta Ophthalmol. 2013; 91(6):e482-e485
Doi: 10.1111/aos.12111
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Boltz, A; Ruiâ, M; Jonas, JB; Tao, Y; Rensch, F; Weger, M; Garhöfer, G; Frantal, S; El-Shabrawi, Y; Schmetterer, L
Role of Vascular Endothelial Growth Factor Polymorphisms in the Treatment Success in Patients with Wet Age-related Macular Degeneration.
Ophthalmology. 2012; 119(8):1615-1620
Doi: 10.1016/j.ophtha.2012.02.001
Web of Science
PubMed
FullText
FullText_MUG
Dunavoelgyi, R; Sacu, S; Eibenberger, K; Palkovits, S; Leydolt, C; Pruente, C; Schmidt-Erfurth, U
Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.
Retina. 2012; 32(8): 1471-1479.
Doi: 10.1097/IAE.0b013e318236e805
Web of Science
PubMed
FullText
FullText_MUG
2011
Schmid-Kubista, KE; Krebs, I; Ansari-Shahrezaei, S; Haas, P; Hagen, S; Binder, S
Comparing treatment of neovascular age-related macular degeneration with sequential intravitreal Avastin and Macugen versus intravitreal mono-therapy--a pilot study.
Curr Eye Res. 2011; 36(10):958-963
Doi: 10.3109/02713683.2011.597536
Web of Science
PubMed
FullText
FullText_MUG
2009
Weiss, K; Steinbrugger, I; Weger, M; Ardjomand, N; Maier, R; Wegscheider, BJ; Wedrich, A; El-Shabrawi, Y
Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab.
Eye. 2009; 23(9): 1812-1818.
Doi: 10.1038/eye.2008.388
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG